Unknown

Dataset Information

0

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.


ABSTRACT: The most common means of mobilizing autologous stem cells is G-CSF alone or combined with cyclophosphamide (CY) to obtain sufficient CD34+ cells for one to two transplants. There are few prospective, randomized studies investigating mobilization regimens in multiple myeloma (MM), especially after lenalidomide-based induction. We designed this prospective, randomized study to compare low-dose CY 2?g/m2 +G-CSF (arm A) and G-CSF alone (arm B) after lenalidomide-based up-front induction in MM. Of the 80 initially randomized patients, 69 patients were evaluable, 34 and 35 patients in arms A and B, respectively. The primary end point was the proportion of patients achieving a yield of ?3 × 10(6)/kg CD34+ cells with 1-2 aphereses, which was achieved in 94% and 77% in arms A and B, respectively (P=0.084). The median number of aphereses needed to reach the yield of ?3 × 10(6)/kg was lower in arm A than in arm B (1 vs. 2, P=0.035). Two patients needed plerixafor in arm A and five patients in arm B (P=0.428). Although CY-based mobilization was more effective, G-CSF alone was successful in a great majority of patients to reach the defined collection target after three cycles of lenalidomide-based induction.

SUBMITTER: Silvennoinen R 

PROVIDER: S-EPMC4777887 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma.

Silvennoinen R R   Anttila P P   Säily M M   Lundan T T   Heiskanen J J   Siitonen T M TM   Kakko S S   Putkonen M M   Ollikainen H H   Terävä V V   Kutila A A   Launonen K K   Räsänen A A   Sikiö A A   Suominen M M   Bazia P P   Kananen K K   Selander T T   Kuittinen T T   Remes K K   Jantunen E E  

Bone marrow transplantation 20151005 3


The most common means of mobilizing autologous stem cells is G-CSF alone or combined with cyclophosphamide (CY) to obtain sufficient CD34+ cells for one to two transplants. There are few prospective, randomized studies investigating mobilization regimens in multiple myeloma (MM), especially after lenalidomide-based induction. We designed this prospective, randomized study to compare low-dose CY 2 g/m2 +G-CSF (arm A) and G-CSF alone (arm B) after lenalidomide-based up-front induction in MM. Of th  ...[more]

Similar Datasets

| S-EPMC3729908 | biostudies-literature
| S-EPMC7817584 | biostudies-literature
| S-EPMC3901994 | biostudies-literature
| S-EPMC6010717 | biostudies-literature
| S-EPMC8378276 | biostudies-literature
| S-EPMC6711992 | biostudies-literature
| S-EPMC2957585 | biostudies-literature
| S-EPMC3946357 | biostudies-literature
| S-EPMC4970832 | biostudies-literature
| S-EPMC7799846 | biostudies-literature